ITPR3

Chr 6AD

inositol 1,4,5-trisphosphate receptor type 3

Inositol 1,4,5-trisphosphate-gated calcium channel that, upon 1D-myo-inositol 1,4,5-trisphosphate binding, transports calcium from the endoplasmic reticulum lumen to cytoplasm, thus releasing the intracellular calcium and therefore participates in cellular calcium ion homeostasis (PubMed:32949214, PubMed:37898605, PubMed:8081734, PubMed:8288584, PubMed:39560673). 1D-myo-inositol 1,4,5-trisphosphate binds to the ligand-free channel without altering its global conformation, yielding the low-energy resting state, then progresses through resting-to preactivated transitions to the higher energy preactivated state, which increases affinity for calcium, promoting binding of the low basal cytosolic calcium at the juxtamembrane domain (JD) site, favoring the transition through the ensemble of high-energy intermediate states along the trajectory to the fully-open activated state (PubMed:30013099, PubMed:35301323, PubMed:37898605). Upon opening, releases calcium in the cytosol where it can bind to the low-affinity cytoplasmic domain (CD) site and stabilizes the inhibited state to terminate calcium release (PubMed:30013099, PubMed:35301323, PubMed:37898605)

Primary Disease Associations & Inheritance

Charcot-Marie-Tooth disease, demyelinating, type 1JMIM #620111
AD
Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathyMIM #621254
AD
539
ClinVar variants
10
Pathogenic / LP
0.00
pLI score
0
Active trials
Clinical SummaryITPR3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
10 Pathogenic / Likely Pathogenic· 297 VUS of 539 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.57LOEUF
pLI 0.000
Z-score 5.70
OE 0.46 (0.370.57)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
4.55Z-score
OE missense 0.69 (0.650.72)
1144 obs / 1667.0 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.46 (0.370.57)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.69 (0.650.72)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.92
01.21.6
LoF obs/exp: 59 / 128.8Missense obs/exp: 1144 / 1667.0Syn Z: 1.69

ClinVar Variant Classifications

539 submitted variants in ClinVar

Classification Summary

Pathogenic6
Likely Pathogenic4
VUS297
Likely Benign78
Benign147
Conflicting7
6
Pathogenic
4
Likely Pathogenic
297
VUS
78
Likely Benign
147
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
5
0
6
Likely Pathogenic
1
2
1
0
4
VUS
5
281
9
2
297
Likely Benign
0
10
16
52
78
Benign
0
6
111
30
147
Conflicting
7
Total630014284539

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ITPR3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Charcot-Marie-Tooth disease, demyelinating, type 1J

MIM #620111

Molecular basis of disorder known

Autosomal dominant

Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy

MIM #621254

Molecular basis of disorder known

Autosomal dominant
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Dominant mutations in ITPR3 cause Charcot-Marie-Tooth disease.
Rönkkö J et al.·Ann Clin Transl Neurol
2020
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →